Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Checking quality of health care records.
Charlton CP, Cuninghame CJ. Charlton CP, et al. BMJ. 1992 May 9;304(6836):1248. doi: 10.1136/bmj.304.6836.1248-c. BMJ. 1992. PMID: 1515814 Free PMC article. No abstract available.
Nasogastric feeding at home: acceptability and safety.
Holden CE, Puntis JW, Charlton CP, Booth IW. Holden CE, et al. Among authors: charlton cp. Arch Dis Child. 1991 Jan;66(1):148-51. doi: 10.1136/adc.66.1.148. Arch Dis Child. 1991. PMID: 1899786 Free PMC article.
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response.
Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK. Merrick VM, et al. J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):274-280. doi: 10.1097/MPG.0000000000001679. J Pediatr Gastroenterol Nutr. 2018. PMID: 29356768
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Kennedy NA, et al. Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. doi: 10.1016/S2468-1253(19)30012-3. Epub 2019 Feb 27. Lancet Gastroenterol Hepatol. 2019. PMID: 30824404
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, Bewshea CM, Chanchlani N, Walker GJ, Perry MH, McDonald TJ, Lees CW, Cummings JRF, Parkes M, Mansfield JC, Irving PM, Barrett JC, McGovern D, Goodhand JR, Anderson CA, Ahmad T; PANTS Consortium. Sazonovs A, et al. Gastroenterology. 2020 Jan;158(1):189-199. doi: 10.1053/j.gastro.2019.09.041. Epub 2019 Oct 7. Gastroenterology. 2020. PMID: 31600487 Free article.
Drug treatment of acute leukaemia. Current status.
Donohue SM, Charlton CP. Donohue SM, et al. Among authors: charlton cp. Drugs. 1989 Jun;37(6):926-38. doi: 10.2165/00003495-198937060-00006. Drugs. 1989. PMID: 2667939 Review.
16 results